Email this article Infusion of esmolol and thoracic epidural anesthesia as methods of intraoperational control of cardiac risk
- Authors: Shayda O.A1, Kobelyatskiy Y.Y.1
-
Affiliations:
- State Institution “Dnepropetrovsk Medical Academy”
- Issue: Vol 7, No 4 (2013)
- Pages: 14-19
- Section: Articles
- URL: https://journals.rcsi.science/1993-6508/article/view/36189
- DOI: https://doi.org/10.17816/ра.v7i4.36189
- ID: 36189
Cite item
Full Text
Abstract
The study was performed to compare thoracic epidural anaesthesia and esmolol infusion capability to provide optimal hemodynamic conditions for myocardial functioning. The study included 45 patients with increased cardiac risk undergoing opened abdominal surgery. The patients were randomized to receive either intravenous anaesthesia or combined (intravenous + thoracic epidural) anaesthesia or intravenous anaesthesia with esmolol infusion. The study results demonstrate that thoracic epidural anaesthesia and esmolol infusion provide effective control of hemodynamic response to trachea intubation and prevent tachycardia during the procedure. B-type natriuretic peptide level decreased during surgery while using two pointed techniques in contrast to the intravenous anaesthesia alone. This fact indicates comfortable conditions for myocardial functioning and proves that these techniques are cardioprotective.
Full Text
##article.viewOnOriginalSite##About the authors
O. A Shayda
State Institution “Dnepropetrovsk Medical Academy”
Yu. Yu Kobelyatskiy
State Institution “Dnepropetrovsk Medical Academy”
References
- Fleisher L.A., Beckman J.A., Brown K.A. et al. 2009 ACCF / AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2009; 54: e13-e118.
- Poldermans D., Bax J.J., Boersma E. et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). European Heart Journal. 2009; 30: 2769-2812.
- Devereaux P.J., Yang H., Yusuf S. et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008; 371: 1839-1847.
- Dunkelgrun M., Boersma E., Schouten O. et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASEIV). Ann Surg. 2009; 249: 921-926.
- Poldermans D., Boersma E., Bax J.J. et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echo-cardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N. Engl. J. Med. 1999; 341: 17891794.
- Raby K.E., Brull S.J., Timimi F. et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth. Analg. 1999; 88: 477-482.
- Beattie W.S., Wijeysundera D.N., Karkouti K. et al. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Anesth. Analg. 2008; 106: 1039-1048.
- Acute pain management: Scientific evidence (3rd edition) / Macintyre P.E., Schug S.A., Scott D.A. et al. Melbourne: ANZ-CA & FPM, 2010. 491 p.
- Beattie W.S., Badner N.H., Choi P. Epidural analgesia reduces postoperative myocardial infarction: A meta-analysis. Anesth. Analg. 2001; 93: 853-858.
- Popping D.M., Elia N., Marret E. et al. Protective effects of epidural analgesia on pulmonary complications after abdominal and thoracic surgery: A meta-analysis. Arch. Surg. 2008; 143(10): 990-999.
- Fox A.A., Marcantonio E.R., Collard C.D. et al. Increased peak postoperative B-type natriuretic peptide predicts decreased longer-term physical function after primary coronary artery bypass graft surgery. Anesthesiology. 2011; 114: 807-816.
- Fox A.A., Muehlschlegel J.D., Body S.C. et al. Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting. Anesthesiology. 2010; 112: 842-851.
- Mahla E., Baumann A., Rehak P. et al. N-terminal pro-brain natriuretic peptide identifies patients at high risk for adverse cardiac outcome aftervascular surgery. Anesthesiology. 2007; 106: 1088-1095.
- Mair J. Biochemistry of B-type natriuretic peptide - where are we now? Clin Chem Lab Med. 2008; 46(11): 1507-1514.
